Delivery Order SPE2DB22D1106-SPE2DB25FEGW9

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award, with ID SPE2DB20D3304|SPE2DB25FW5Q8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,378.43, is a Firm Fixed Price Delivery Order for the procurement of PROCTOFOAM-HC 1%-1% FOAM 10GM medical supplies. The contract has a completion date of March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,045.51, is a delivery order to supply PROCTOFOAM-HC 1%-1% FOAM 10GM medical products. The contract has a ceiling value of $3,045.51 and a completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,990.92 firm fixed-price delivery order is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,257.60 firm fixed-price delivery order contract is for the supply of PROCTOFOAM-HC 1%-1% FOAM 10GM, a medical product. The contract has a completion date of December 23, 2024 and was awarded on December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,173.14 Firm Fixed Price delivery order is for the medical product "PROCTOFOAM-HC 1%-1% FOAM 10GM" and has a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,609.84, is a delivery order for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,902.50, covers the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical commodities across various...
This federal contract award was granted by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $31,644.36, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract covers a broad range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of a wide range of pharmaceutical products and medical supplies. The contract, with a ceiling value of $74,581.98, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. This IDC serves as...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEGW9
    Delivery Order

This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEGW9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, with a ceiling value of $7,543.77 and a completion date of April 9, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award does not have a set-aside designation, indicating open competition.

Generated 7/8/25, 2:39 PM